🎥 GARDP posted a video
🏷️ https://unjobs.org/themes/antimicrobial-resistance
🏷️ https://unjobs.org/themes/antimicrobial-resistance
Using artificial intelligence to analyse and predict susceptibility to antimicrobials
Speakers:
Adrian Egli, Director, Institute of Medical Microbiology, University of Zürich (Switzerland)
Javier Fernández Domínguez, co-founder and co-CEO, Pragmatech AI Solutions (Spain)
Moderator: Margo Diricks, Postdoctoral researcher, Research Center Borstel – Leibniz Lung Center (Germany)
Schedule:
0:00 Webinar opening words
03:35 Presentation 1: Using AI to analyse microbiological diagnostic data and detect antimicrobial resistance (Adrian Egli)
27:37 Presentation 2: Applying AI to analyze susceptibility to antimicrobials (Javier Fernández Domínguez)
55:15 Questions & Answers
GARDP: https://www.gardp.org/
REVIVE: https://revive.gardp.org/
www.youtube.com
November 2, 2025 at 10:24 PM
🎥 GARDP posted a video
🏷️ https://unjobs.org/themes/antimicrobial-resistance
🏷️ https://unjobs.org/themes/antimicrobial-resistance
🌍 The ComBac-Africa website is now live!
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
ComBac-Africa | Fighting AMR in Sub-Saharan Africa
Advancing diagnostics and antimicrobial stewardship in Africa to combat drug-resistant bacteria and improve treatment access.
www.combac-africa.org
October 30, 2025 at 6:53 AM
🌍 The ComBac-Africa website is now live!
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach.
🔗 www.combac-africa.org
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
October 23, 2025 at 6:06 AM
🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.
A Communications Medicine publication proposes a comprehensive One Health stewardship framework to address AMR. CARB-X and Global Antibiotic R&D Partnership (GARDP) are recognized as important push incentives supporting antibiotic R&D. #IDSky 🧪
🔗 Read here: bit.ly/3KSyMvh
🔗 Read here: bit.ly/3KSyMvh
October 17, 2025 at 5:07 PM
A Communications Medicine publication proposes a comprehensive One Health stewardship framework to address AMR. CARB-X and Global Antibiotic R&D Partnership (GARDP) are recognized as important push incentives supporting antibiotic R&D. #IDSky 🧪
🔗 Read here: bit.ly/3KSyMvh
🔗 Read here: bit.ly/3KSyMvh
This year’s BioJapan saw a significant increase in attendance, with more than a 20% rise compared to last year📈
We are deeply grateful to everyone who visited the GARDP booth, showing warm interest and asking thoughtful questions🙏
GARDP will continue to address the global health challenge of #AMR🌍
We are deeply grateful to everyone who visited the GARDP booth, showing warm interest and asking thoughtful questions🙏
GARDP will continue to address the global health challenge of #AMR🌍
October 16, 2025 at 8:12 AM
This year’s BioJapan saw a significant increase in attendance, with more than a 20% rise compared to last year📈
We are deeply grateful to everyone who visited the GARDP booth, showing warm interest and asking thoughtful questions🙏
GARDP will continue to address the global health challenge of #AMR🌍
We are deeply grateful to everyone who visited the GARDP booth, showing warm interest and asking thoughtful questions🙏
GARDP will continue to address the global health challenge of #AMR🌍
When asked what GARDP expects from Japan in the fight against #AMR at the Nikkei-FT Infectious Disease Conference session, Rahul Dwivedi of #GARDP said:
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
“Japan’s leadership is vital—especially in enabling access. With
Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”
October 13, 2025 at 3:02 AM
GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror.
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
Co-creating an innovative AI platform to advance global health research | Medicines for Malaria Venture
Researchers from around the world collaborate with MMV and deepmirror to adapt machine-learning platform to accelerate drug discovery.
www.mmv.org
October 10, 2025 at 6:17 AM
GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror.
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
It aims to accelerate identification of promising drug compounds for global health research.
🔗 bit.ly/4h0I1pe
Finally, #BioJapan2025 starts tomorrow!
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
October 7, 2025 at 7:35 AM
Finally, #BioJapan2025 starts tomorrow!
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
📍October 8–10 | Pacifico Yokohama
This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨
💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!
#SwissInnovation #AMR
🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
October 7, 2025 at 7:33 AM
🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR.
GARDP calls for focus on four key areas:
1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response
🔗 bit.ly/48NxgV8
GARDP calls for focus on four key areas:
1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response
🔗 bit.ly/48NxgV8
GARDP Statement on the Global Action Plan on AMR update | GARDP
In May 2026, the World Health Assembly will consider adoption of an updated World Health Organization (WHO) Global Action Plan on AMR (GAP). The initial action
bit.ly
October 6, 2025 at 11:15 AM
The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR.
GARDP calls for focus on four key areas:
1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response
🔗 bit.ly/48NxgV8
GARDP calls for focus on four key areas:
1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response
🔗 bit.ly/48NxgV8
"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."
– Jennifer Cohn, GARDP
– Jennifer Cohn, GARDP
October 5, 2025 at 2:28 AM
"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."
– Jennifer Cohn, GARDP
– Jennifer Cohn, GARDP
This week, GARDP joined the PDP Funders Group in Thailand.
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
October 4, 2025 at 10:13 AM
This week, GARDP joined the PDP Funders Group in Thailand.
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
Highlights from the visit 👇
🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.
🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
October 4, 2025 at 8:58 AM
The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
🎤 GARDP team members Alan Hennessy, Renata da Costa, and Dianna Taylor presented at #GAMRIC2025.
Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India
Excited to share insights on antibiotic R&D and access!
Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India
Excited to share insights on antibiotic R&D and access!
October 3, 2025 at 2:08 PM
🎤 GARDP team members Alan Hennessy, Renata da Costa, and Dianna Taylor presented at #GAMRIC2025.
Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India
Excited to share insights on antibiotic R&D and access!
Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India
Excited to share insights on antibiotic R&D and access!
The rise in neonatal sepsis caused by drug-resistant bacteria is a major concern.
GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍
www.newsweek.com/drug-resista...
GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍
www.newsweek.com/drug-resista...
Drug-resistant infections in newborns rising across asia
Sydney researchers are calling for updated guidelines and accelerated drug development.
www.newsweek.com
October 3, 2025 at 12:02 PM
The rise in neonatal sepsis caused by drug-resistant bacteria is a major concern.
GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍
www.newsweek.com/drug-resista...
GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍
www.newsweek.com/drug-resista...
🤝 The GARDP team visited Japan’s Ministry of Health, Labour and Welfare (International Affairs & Infectious Disease Divisions) to thank the Government of Japan for its support from 2020 to 2025.
💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.
💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.
October 3, 2025 at 6:38 AM
🤝 The GARDP team visited Japan’s Ministry of Health, Labour and Welfare (International Affairs & Infectious Disease Divisions) to thank the Government of Japan for its support from 2020 to 2025.
💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.
💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.
In a GARDP-led session at the #GAMRIC, Alison Luckey, our Associate Director of Medical Sciences emphasized inclusivity in STI research.
October 1, 2025 at 1:30 PM
In a GARDP-led session at the #GAMRIC, Alison Luckey, our Associate Director of Medical Sciences emphasized inclusivity in STI research.
🔴 Live from London!
GARDP is at the first-ever #GAMRIC.
In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter.
More updates🔜
GARDP is at the first-ever #GAMRIC.
In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter.
More updates🔜
October 1, 2025 at 1:06 PM
🔴 Live from London!
GARDP is at the first-ever #GAMRIC.
In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter.
More updates🔜
GARDP is at the first-ever #GAMRIC.
In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter.
More updates🔜
4️⃣ GARDP booth
Meet our team, exchange ideas and discover GARDP’s work over the years.
We look forward to connecting with brilliant minds working to deliver better answers to the growing threat of antimicrobial resistance.
See you in London!
#GAMRIC2025
Meet our team, exchange ideas and discover GARDP’s work over the years.
We look forward to connecting with brilliant minds working to deliver better answers to the growing threat of antimicrobial resistance.
See you in London!
#GAMRIC2025
September 26, 2025 at 8:10 AM
4️⃣ GARDP booth
Meet our team, exchange ideas and discover GARDP’s work over the years.
We look forward to connecting with brilliant minds working to deliver better answers to the growing threat of antimicrobial resistance.
See you in London!
#GAMRIC2025
Meet our team, exchange ideas and discover GARDP’s work over the years.
We look forward to connecting with brilliant minds working to deliver better answers to the growing threat of antimicrobial resistance.
See you in London!
#GAMRIC2025
2️⃣ 𝐓𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐀𝐌𝐑 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐨𝐟 𝐒𝐞𝐱𝐮𝐚𝐥𝐥𝐲 𝐓𝐫𝐚𝐧𝐬𝐦𝐢𝐭𝐭𝐞𝐝 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬: 𝐀 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐬
A GARDP-led session moderated by Seamus O’Brien, with Alison Luckey FFPM as speaker and panelist.
📅 1 Oct | 13:00–14:30 (GMT+1)
A GARDP-led session moderated by Seamus O’Brien, with Alison Luckey FFPM as speaker and panelist.
📅 1 Oct | 13:00–14:30 (GMT+1)
September 26, 2025 at 8:10 AM
2️⃣ 𝐓𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐀𝐌𝐑 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐨𝐟 𝐒𝐞𝐱𝐮𝐚𝐥𝐥𝐲 𝐓𝐫𝐚𝐧𝐬𝐦𝐢𝐭𝐭𝐞𝐝 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬: 𝐀 𝐅𝐨𝐜𝐮𝐬 𝐨𝐧 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐬
A GARDP-led session moderated by Seamus O’Brien, with Alison Luckey FFPM as speaker and panelist.
📅 1 Oct | 13:00–14:30 (GMT+1)
A GARDP-led session moderated by Seamus O’Brien, with Alison Luckey FFPM as speaker and panelist.
📅 1 Oct | 13:00–14:30 (GMT+1)
🆕 In early October, the global #AMR research community will gather in London for the first-ever 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐌𝐑 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐆𝐀𝐌𝐑𝐈𝐂), and we’re proud to co-organize this inaugural event.
Here’s where you can find GARDP:
Here’s where you can find GARDP:
September 26, 2025 at 8:10 AM
🆕 In early October, the global #AMR research community will gather in London for the first-ever 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐌𝐑 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐆𝐀𝐌𝐑𝐈𝐂), and we’re proud to co-organize this inaugural event.
Here’s where you can find GARDP:
Here’s where you can find GARDP:
CDC reports that the 'nightmare bacteria' with the NDM gene infections rose ~ 70% from 2019–2023 & is resistant to almost all antibiotics.
At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it.
🔗Read: bit.ly/4pFG05H
At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it.
🔗Read: bit.ly/4pFG05H
‘Nightmare bacteria’ cases are increasing in the U.S.
It’s likely that many people are unrecognized carriers of the drug-resistant bacteria, which could lead to community spread, CDC scientists said.
bit.ly
September 26, 2025 at 6:00 AM
CDC reports that the 'nightmare bacteria' with the NDM gene infections rose ~ 70% from 2019–2023 & is resistant to almost all antibiotics.
At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it.
🔗Read: bit.ly/4pFG05H
At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it.
🔗Read: bit.ly/4pFG05H
🌍 At #UNGA80, GARDP joined the Union for International Cancer Control (UICC) & Norwegian Cancer Society for a side event with leaders from Norway and Mozambique to mobilize efforts to fight #AMR and improve cancer care.
💬Jennifer Cohn underlined GARDP’s role in improving antibiotic access in LMICs.
💬Jennifer Cohn underlined GARDP’s role in improving antibiotic access in LMICs.
September 25, 2025 at 10:28 AM
🎥 GARDP posted a video
🏷️ https://unjobs.org/themes/tuberculosis
🏷️ https://unjobs.org/themes/tuberculosis
Overcoming challenges of tuberculosis drug discovery and development
Speakers:
Jeremy Rock, Associate Professor, Rockefeller University (USA)
Dirk Schnappinger, Professor, Department of Microbiology & Immunology, Weill Cornell Medical College (USA)
Laura Cleghorn, Reader, Drug Discovery Unit, School of Life Sciences, University of Dundee (UK)
Moderator: Valerie Mizrahi, Director, Institute of Infectious Disease and Molecular Medicine, University of Cape Town (South Africa)
Schedule:
0:00 Webinar opening words
03:34 Presentation 1: Identifying vulnerable targets and pathways in M. tuberculosis (Jeremy Rock)
27:26 Presentation 2: The application of chemical-genetic tools in TB drug discovery (Dirk Schnappinger)
53:21 Presentation 3: Opportunities and challenges in TB drug discovery: targeting Pks13 as a case study (Laura Cleghorn)
01:14:32 Questions & Answers
GARDP: https://www.gardp.org/
REVIVE: https://revive.gardp.org/
www.youtube.com
September 20, 2025 at 1:48 AM
🎥 GARDP posted a video
🏷️ https://unjobs.org/themes/tuberculosis
🏷️ https://unjobs.org/themes/tuberculosis